CD44 is associated with papillary thyroid carcinoma metastasis via potential modulation of the immunosuppressive tumor microenvironment.
Saved in:
| Title: | CD44 is associated with papillary thyroid carcinoma metastasis via potential modulation of the immunosuppressive tumor microenvironment. |
|---|---|
| Authors: | Adeerjiang Y; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China., Huo MH; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China.; Department of Gastroenterology and Endocrinology, Tianjin Haihe Hospital, Tianjin, China., Ma L; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China.; Department of Endocrinology, The Friendship Hospital of ILY Kazak Autonomous Pefecture, Yining, China., Li XX; Department of Endocrine surgery, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China., Tian Y; Department of Endocrine surgery, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China., Bai C; Department of Endocrine surgery, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China., Wang BW; Department of Pathology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China., Qu X; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China., Yao XY; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China., Ma LL; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China., Gan XX; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China., Kuang JY; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China., Liang HZ; Suzhou Industrial Park Monash Research Institute of Science and Technology, Suzhou, Jiangsu Province, China.; Southeast University-Monash University Joint Graduate School, Suzhou, Jiangsu Province, China.; Monash University-Southeast University Joint Research Institute, Suzhou, Jiangsu Province, China., Qiang BR; Department of Endocrinology, Bayingolin Mongolian Autonomous Prefecture People's Hospital, Kuerle, China., Wang R; Department of Endocrinology, Bayingolin Mongolian Autonomous Prefecture People's Hospital, Kuerle, China., Bao JL; Medical Experimental Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. 24533026@qq.com., Jiang S; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. xjjsh@126.com.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China. xjjsh@126.com., Du GL; Department of Endocrinology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. genemagic@126.com.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China. genemagic@126.com.; Department of Endocrinology, Bayingolin Mongolian Autonomous Prefecture People's Hospital, Kuerle, China. genemagic@126.com. |
| Source: | Clinical and experimental medicine [Clin Exp Med] 2026 Feb 25; Vol. 26 (1). Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1591-9528 |
|---|---|
| DOI: | 10.1007/s10238-026-02101-x |
